| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics, Inc. | Chief Medical Officer | Class A Common Stock | 50,947 | $2,138,953 | $41.98 | 23 Feb 2026 | Direct |
| Vera Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 50,000 | 04 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 23 Feb 2026 | 1 | -$90,307 | 4 | Chief Medical Officer | 25 Feb 2026, 20:01 |
| VERA | Vera Therapeutics, Inc. | 04 Feb 2026 | 2 | $0 | 4 | Chief Medical Officer | 06 Feb 2026, 20:00 |
| VERA | Vera Therapeutics, Inc. | 18 Feb 2025 | 2 | $0 | 4 | Chief Medical Officer | 20 Feb 2025, 16:10 |
| VERA | Vera Therapeutics, Inc. | 03 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 08 Jan 2024, 08:17 |
| VERA | Vera Therapeutics, Inc. | 03 Jan 2024 | 0 | $0 | 3 | Chief Medical Officer | 08 Jan 2024, 08:15 |